Angiotensin II type 2 receptor agonists: where should they be applied?
about
Pharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers?Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta.Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.Commercially available angiotensin II At₂ receptor antibodies are nonspecific.The Angiotensin II Type 2 Receptor in Brain Functions: An Update.Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.Angiotensin II type 2 receptor agonists--where should they be applied?Key developments in renin-angiotensin-aldosterone system inhibition.Update on the angiotensin AT(2) receptor.How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?Targeting the 'Janus face' of the B2-bradykinin receptor.Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain.Propofol inhibits expression of angiotensin II receptor type 2 in dorsal root ganglion neurons.Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats.Raman micro-spectroscopy as a viable tool to monitor and estimate the ionic transport in epithelial cells.Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.The Effect of a Non-peptide Angiotensin II type 2 receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome.Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone.
P2860
Q26775758-F06D9F58-970A-4C36-8B6F-76D3C3E0C170Q33782669-091666EC-0A35-4CFC-928A-D5EFF51C4422Q34001678-E2197787-E682-422C-81CC-82DE33803849Q34809342-04615271-1FE3-4B46-A971-6F23AFEA9D78Q36520049-DBB6DB7F-EEE1-4002-830D-CD471C5BCEE0Q37147092-74A8782D-F137-4916-8726-F3DA9594CCB4Q38004057-4341AFA7-8BC0-4D3F-B631-28F8905FF963Q38061004-6E1F69A5-2284-494B-B0AF-950FBC2ADC09Q38066000-228710F0-DFC6-46AA-8CBF-75590862C73BQ38069825-D4E2B140-C052-472A-A5B7-E0DD5C57F654Q38129928-C4582AA1-C874-485F-B967-B7E3FF21FA5FQ38260195-9E4779B9-44AF-48B7-B4C9-EC50C308C2A8Q39156357-B5B48FFA-F57A-4FAF-BA08-4ED0D6DE5E13Q41818299-A3462084-E702-46B5-AE59-F0640A8DC4F9Q41821770-F596AF54-0B60-4798-BE8F-E4498C04B3FAQ43880703-904C0AD6-7BA1-448A-A464-313D6E5307C4Q47752010-BCC24608-7BEC-4CA1-98AD-DF1B673123FDQ54964058-019E9DC7-C3AC-461C-AA04-23781D786365
P2860
Angiotensin II type 2 receptor agonists: where should they be applied?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Angiotensin II type 2 receptor agonists: where should they be applied?
@en
Angiotensin II type 2 receptor agonists: where should they be applied?
@nl
type
label
Angiotensin II type 2 receptor agonists: where should they be applied?
@en
Angiotensin II type 2 receptor agonists: where should they be applied?
@nl
prefLabel
Angiotensin II type 2 receptor agonists: where should they be applied?
@en
Angiotensin II type 2 receptor agonists: where should they be applied?
@nl
P2093
P2860
P1476
Angiotensin II type 2 receptor agonists: where should they be applied?
@en
P2093
A H Jan Danser
Joep H M van Esch
Koen Verdonk
P2860
P304
P356
10.1517/13543784.2012.664131
P407
P577
2012-02-21T00:00:00Z